Evofem Biosciences

Update in progress

EVFM (OTC Markets OTCID)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

Evofem Biosciences, Inc. is a biopharmaceutical company focused on women’s sexual and reproductive health. It develops and commercializes products to address unmet needs, including PHEXXI, a hormone-free contraceptive vaginal gel, and SOLOSEC, a single-dose oral antimicrobial for bacterial vaginosis and trichomoniasis. The company is headquartered in San Diego, California.

Company score

Sentiment: -0.04; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.12; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.02; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.04; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.00; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive

Company

MarketOTC Markets OTCID (OID)
LocationUnited States
CEOMs. Saundra Pelletier
Employees29
Websitewww.evofem.com

Identifiers

ISINUS30048L2034
FIGIBBG0026ZG450
CUSIP30048L104
CIK0001618835